Your browser doesn't support javascript.
loading
Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors.
Nijenhuis, Cynthia M; Hellriegel, Edward; Beijnen, Jos H; Hershock, Diane; Huitema, Alwin D R; Lucas, Luc; Mergui-Roelvink, Marja; Munteanu, Mihaela; Rabinovich-Guilatt, Laura; Robertson, Philmore; Rosing, Hilde; Spiegelstein, Ofer; Schellens, Jan H M.
Afiliación
  • Nijenhuis CM; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands.
  • Hellriegel E; Teva Branded Pharmaceutical Products R&D, Nonclinical DMPK, West Chester, PA, USA.
  • Beijnen JH; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands.
  • Hershock D; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Huitema AD; Teva Branded Pharmaceutical Products R&D, Oncology Clinical Development, Frazer, PA, USA.
  • Lucas L; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands.
  • Mergui-Roelvink M; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands.
  • Munteanu M; Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rabinovich-Guilatt L; Teva Branded Pharmaceutical Products R&D, Oncology Clinical Development, Frazer, PA, USA.
  • Robertson P; ImmunoGen, Inc, Waltham, MA, USA.
  • Rosing H; Teva Global Branded Products, 41 Moores Road, PO Box 4011, Frazer, PA, 19355, USA. laura.rabinovich@tevapharm.com.
  • Spiegelstein O; Teva Branded Pharmaceutical Products R&D, Nonclinical DMPK, West Chester, PA, USA.
  • Schellens JH; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands.
Invest New Drugs ; 34(5): 565-74, 2016 10.
Article en En | MEDLINE | ID: mdl-27221729
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Harringtoninas / Neoplasias / Antineoplásicos Fitogénicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Harringtoninas / Neoplasias / Antineoplásicos Fitogénicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos